Advanced search
Publication Cover
Current Medical Research and Opinion Volume 38, 2022 - Issue 5
Submit an article Journal homepage
2,795
Views
2
CrossRef citations to date
0
Altmetric
Rheumatology

Current status of shared decision making for rheumatoid arthritis treatment in Japan: a web-based survey on physicians and patients

Hiroto Tsuboia Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, JapanORCID Iconhttps://orcid.org/0000-0001-9067-0961
ORCID Icon,
Yuko Kanekob Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0003-2646-5765
ORCID Icon,
Kei Ikedac Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
,
Toshihiko Aranishid Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K, Kobe, JapanORCID Iconhttps://orcid.org/0000-0001-8862-9468
ORCID Icon,
Zhihong Caid Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K, Kobe, Japan
&
Tomoko Ishizukad Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K, Kobe, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7416-7474
ORCID Icon
Pages 853-861 | Received 13 Sep 2021, Accepted 02 Mar 2022, Published online: 24 Mar 2022

References

  • Kojima M, Nakayama T, Tsutani K, et al. Epidemiological characteristics of rheumatoid arthritis in Japan: prevalence estimates using a nationwide population-based questionnaire survey. Mod Rheumatol. 2020;30(6):941–947.
  • Yamanaka H, Sugiyama N, Inoue E, et al. Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I). Mod Rheumatol. 2014;24(1):33–40.
  • Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of rheumatology/European League against rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–2581.
  • Smolen JS, Landewé RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79(6):685–699.
  • Aoki A, Suda A, Nagaoka S, et al. Preferences of Japanese rheumatoid arthritis patients in treatment decision-making. Mod Rheumatol. 2013;23(5):891–896.
  • Kaneko Y, Sato M, Cai Z, et al. Assessment of discordance of treatment satisfaction between patients with rheumatoid arthritis in low disease activity or in remission and their treating physicians: a cross-sectional survey. Mod Rheumatol. 2021;31(2):326–333.
  • Elwyn G, Edwards A, Kinnersley P. Shared decision-making in primary care: the neglected second half of the consultation. Br J Gen Pract. 1999;49(443):477–482.
  • Elwyn G, Edwards A, Gwyn R, et al. Towards a feasible model for shared decision making: focus group study with general practice registrars. BMJ. 1999;319(7212):753–756.
  • Spatz ES, Krumholz HM, Moulton BW. The new era of informed consent: getting to a reasonable-patient standard through shared decision making. JAMA. 2016;315(19):2063–2064.
  • Ramiro S, Sepriano A, Chatzidionysiou K, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis. 2017;76(6):1101–1136.
  • Smolen JS, Landewé R, Bijlsma J, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76(6):960–977.
  • Goto Y, Miura H, Son D, et al. Psychometric evaluation of the Japanese 9-item Shared Decision-Making Questionnaire and its association with decision conflict and patient factors in Japanese Primary Care. JMA J. 2020;3(3):208–215.
  • Kriston L, Scholl I, Hölzel L, et al. The 9-item Shared Decision Making Questionnaire (SDM-Q-9). Development and psychometric properties in a primary care sample. Patient Educ Couns. 2010;80(1):94–99.
  • Scholl I, Kriston L, Dirmaier J, et al. Development and psychometric properties of the Shared Decision Making Questionnaire-physician version (SDM-Q-Doc). Patient Educ Couns. 2012;88(2):284–290.
  • Mahlich J, Matsuoka K, Sruamsiri R. Shared decision making and treatment satisfaction in Japanese patients with inflammatory bowel disease. Dig Dis. 2017;35(5):454–462.
  • Lofland JH, Johnson PT, Ingham MP, et al. Shared decision-making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs. Patient Prefer Adherence. 2017;11:947–958.
  • O’Neill KD, Marks KE, Sinicrope PS, et al. Importance of shared treatment goal discussions in rheumatoid arthritis-a cross-sectional survey: patients report providers seldom discuss treatment goals and outcomes improve when goals are discussed. ACR Open Rheumatol. 2021;3(12):870–878.
  • Roodenrijs NMT, van der Goes MC, Welsing PMJ, et al. Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease. Rheumatology. 2021;60(8):3778–3788.
  • de Toro J, González CM, Cea-Calvo L, et al. Patients’ perceptions on shared decision making during prescription of subcutaneous biological drug treatments for inflammatory arthritis: the RHEU-LIFE survey. Musculoskeletal Care. 2020;18(4):568–574.
  • Ministry of Health, Labour and Welfare [Internet]. Statistics of Physicians, Dentists and Pharmacists 2018. Statistical Surveys conducted by Ministry of Health, Labour and Welfare; [cited 5 Nov 2021]. Available from: https://www.mhlw.go.jp/toukei/saikin/hw/ishi/18/dl/gaikyo.pdf. Japanese.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.